Anika Therapeutics (NASDAQ:ANIK) manufactures and distributes a diverse portfolio of hyaluronic acid-based products covering a broad range of therapeutic applications. Anika's stock has seen a decent rally of ~25% since October. I expect the sock to appreciate further from the current level around $31 driven by the robust growth of the company's orthobiologics and aesthetic dermatology products.
Anika develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid ("HA"), also known as hyaluronan, a naturally occurring biocompatible polymer found in the body. Anika produces a variety of HA products, such as liquids, gels, powders and sponge-like membranes, and packages these products for convenient delivery.
Anika's orthobiologics products...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|